Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia.

Vorselaars VMM, Hosman AE, Westermann CJJ, Snijder RJ, Mager JJ, Goumans MJ, Post MC.

Int J Mol Sci. 2018 Oct 17;19(10). pii: E3203. doi: 10.3390/ijms19103203. Review.

2.

Association of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia.

Pawlikowska L, Nelson J, Guo DE, McCulloch CE, Lawton MT, Kim H, Faughnan ME; Brain Vascular Malformation Consortium HHT Investigator Group.

Mol Genet Genomic Med. 2018 May;6(3):350-356. doi: 10.1002/mgg3.377. Epub 2018 Mar 6.

3.

Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia.

Vorselaars VMM, Velthuis S, Huitema MP, Hosman AE, Westermann CJJ, Snijder RJ, Mager JJ, Post MC.

Neth Heart J. 2018 Apr;26(4):203-209. doi: 10.1007/s12471-018-1094-4.

4.

Executive summary of the 12th HHT international scientific conference.

Andrejecsk JW, Hosman AE, Botella LM, Shovlin CL, Arthur HM, Dupuis-Girod S, Buscarini E, Hughes CCW, Lebrin F, Mummery CL, Post MC, Mager JJ.

Angiogenesis. 2018 Feb;21(1):169-181. doi: 10.1007/s10456-017-9585-2.

5.

SMAD4 gene mutation increases the risk of aortic dilation in patients with hereditary haemorrhagic telangiectasia.

Vorselaars VMM, Diederik A, Prabhudesai V, Velthuis S, Vos JA, Snijder RJ, Westermann CJJ, Mulder BJ, Ploos van Amstel JK, Mager JJ, Faughnan ME, Post MC.

Int J Cardiol. 2017 Oct 15;245:114-118. doi: 10.1016/j.ijcard.2017.06.059.

PMID:
28874282
6.

Screening children for pulmonary arteriovenous malformations: Evaluation of 18 years of experience.

Hosman AE, de Gussem EM, Balemans WAF, Gauthier A, Westermann CJJ, Snijder RJ, Post MC, Mager JJ.

Pediatr Pulmonol. 2017 Sep;52(9):1206-1211. doi: 10.1002/ppul.23704. Epub 2017 Apr 13.

PMID:
28407366
7.

Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia.

de Gussem EM, Edwards CP, Hosman AE, Westermann CJ, Snijder RJ, Faughnan ME, Mager JJ.

Orphanet J Rare Dis. 2016 Apr 22;11:46. doi: 10.1186/s13023-016-0427-x.

8.

Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia.

Vorselaars VM, Velthuis S, Snijder RJ, Westermann CJ, Vos JA, Mager JJ, Post MC.

Eur Respir J. 2016 Jun;47(6):1750-7. doi: 10.1183/13993003.01588-2015. Epub 2016 Mar 10.

9.

Interaction Between ALK1 Signaling and Connexin40 in the Development of Arteriovenous Malformations.

Gkatzis K, Thalgott J, Dos-Santos-Luis D, Martin S, Lamandé N, Carette MF, Disch F, Snijder RJ, Westermann CJ, Mager JJ, Oh SP, Miquerol L, Arthur HM, Mummery CL, Lebrin F.

Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):707-17. doi: 10.1161/ATVBAHA.115.306719. Epub 2016 Jan 28.

PMID:
26821948
10.

Follow-up of Thalidomide treatment in patients with Hereditary Haemorrhagic Telangiectasia.

Hosman A, Westermann CJ, Snijder R, Disch F, Mummery CL, Mager JJ.

Rhinology. 2015 Dec;53(4):340-4. doi: 10.4193/Rhin14.289.

PMID:
26735132
11.

Thoracic aorta dilation in patients with hereditary hemorrhagic telangiectasia due to SMAD4 gene mutation.

Vorselaars VM, Velthuis S, Snijder RJ, Mager JJ, Post MC.

Am J Med Genet A. 2016 Mar;170(3):811-2. doi: 10.1002/ajmg.a.37465. Epub 2015 Nov 14. No abstract available.

PMID:
26566607
12.

Pulmonary hypertension in hereditary haemorrhagic telangiectasia.

Vorselaars VM, Velthuis S, Snijder RJ, Vos JA, Mager JJ, Post MC.

World J Cardiol. 2015 May 26;7(5):230-7. doi: 10.4330/wjc.v7.i5.230.

13.

Quality of life in pulmonary arterial hypertension.

Post MC, Mager JJ.

Neth Heart J. 2015 May;23(5):275-7. doi: 10.1007/s12471-015-0671-z. No abstract available.

14.

Reply to comments and questions of Dr. Correale et al. about our review concerning CTEPH.

Schölzel BE, Snijder RJ, Mager JJ, van Es HW, Plokker HW, Reesink HJ, Morshuis WJ, Post MC.

Neth Heart J. 2015 Mar;23(3):194-5. doi: 10.1007/s12471-015-0668-7. No abstract available.

15.

Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia.

Kim H, Nelson J, Krings T, terBrugge KG, McCulloch CE, Lawton MT, Young WL, Faughnan ME; Brain Vascular Malformation Consortium HHT Investigator Group.

Stroke. 2015 May;46(5):1362-4. doi: 10.1161/STROKEAHA.114.007367. Epub 2015 Apr 9.

16.

The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.

Pawlikowska L, Nelson J, Guo DE, McCulloch CE, Lawton MT, Young WL, Kim H, Faughnan ME; Brain Vascular Malformation Consortium HHT Investigator Group.

Am J Med Genet A. 2015 Jun;167(6):1262-7. doi: 10.1002/ajmg.a.36936. Epub 2015 Apr 2.

17.

Percutaneous left atrial appendage closure-An alternative strategy for anticoagulation in atrial fibrillation and hereditary hemorrhagic telangiectasia?

Vorselaars VM, Velthuis S, Swaans MJ, Mager JJ, Snijder RJ, Rensing BJ, Boersma LV, Post MC.

Cardiovasc Diagn Ther. 2015 Feb;5(1):49-53. doi: 10.3978/j.issn.2223-3652.2015.01.02.

18.

Clinical implications of pulmonary shunting on saline contrast echocardiography.

Velthuis S, Buscarini E, Gossage JR, Snijder RJ, Mager JJ, Post MC.

J Am Soc Echocardiogr. 2015 Mar;28(3):255-63. doi: 10.1016/j.echo.2014.12.008. Epub 2015 Jan 23. Review.

PMID:
25623000
19.

Pulmonary shunt fraction measurement compared to contrast echocardiography in hereditary haemorrhagic telangiectasia patients: time to abandon the 100% oxygen method?

Velthuis S, Vorselaars VM, Westermann CJ, Snijder RJ, Mager JJ, Post MC.

Respiration. 2015;89(2):112-8. doi: 10.1159/000368416. Epub 2015 Jan 21.

20.

[A young man with intestinal polyposis and epistaxis].

Menko FH, Jacobs MA, Mager JJ, Nicolaï JJ, Mensenkamp AR, Aalfs CM.

Ned Tijdschr Geneeskd. 2014;158:A7398. Dutch.

PMID:
25269631

Supplemental Content

Loading ...
Support Center